Literature DB >> 20723896

Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes.

Gemma Aragonès1, Raimon Ferré, Iolanda Lázaro, Anna Cabré, Núria Plana, Jordi Merino, Mercedes Heras, Josefa Girona, Lluís Masana.   

Abstract

OBJECTIVE: Adipocyte fatty acid-binding protein (FABP4) plasma levels are higher in type 2 diabetes (T2D). Endothelial dysfunction is also common in T2D. We have investigated the relationship between circulating FABP4 levels and endothelial function in diabetic patients.
METHODS: In 257 patients (105 diabetic and 152 non-diabetic) at increased risk of cardiovascular disease, we measured circulating FABP4, reactive hyperemia index (RHI) by peripheral artery tonometry, intima-media thickness, and biomarkers of inflammation, oxidation and endothelial function.
RESULTS: In T2D subjects, FABP4 was negatively associated with endothelial function, as measured by RHI (r=-0.226, P=0.05). In a stepwise multivariate linear regression model, FABP4 was a predictor of RHI in T2D patients (P=0.04).
CONCLUSION: Circulating levels of FABP4 are inversely associated with endothelial function in T2D patients, as measured by RHI. We suggest a direct effect of plasma FABP4 on the vascular endothelium in those with T2D.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20723896     DOI: 10.1016/j.atherosclerosis.2010.07.026

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  26 in total

1.  The effect of progesterone dose on gene expression after traumatic brain injury.

Authors:  Gail D Anderson; Federico M Farin; Theo K Bammler; Richard P Beyer; Alicia A Swan; Hui-Wen Wilkerson; Eric D Kantor; Michael R Hoane
Journal:  J Neurotrauma       Date:  2011-09-08       Impact factor: 5.269

Review 2.  The Role of Adipocytokines in Coronary Atherosclerosis.

Authors:  Luca Liberale; Aldo Bonaventura; Alessandra Vecchiè; Matteo Casula; Franco Dallegri; Fabrizio Montecucco; Federico Carbone
Journal:  Curr Atheroscler Rep       Date:  2017-02       Impact factor: 5.113

Review 3.  Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction.

Authors:  Ping Gu; Aimin Xu
Journal:  Rev Endocr Metab Disord       Date:  2013-03       Impact factor: 6.514

4.  Prognostic Utility of Fatty Acid-Binding Protein 4 in Patients with Type 2 Diabetes and Acute Ischemic Stroke.

Authors:  Siou Li; Pengxiang Bi; Weina Zhao; Yifei Lian; Haifu Zhu; Dan Xu; Jiayuan Ding; Quankui Wang; Changhao Yin
Journal:  Neurotox Res       Date:  2017-08-11       Impact factor: 3.911

Review 5.  Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2.

Authors:  Yu Wang
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

6.  Retinol-binding protein 7 is an endothelium-specific PPARγ cofactor mediating an antioxidant response through adiponectin.

Authors:  Chunyan Hu; Henry L Keen; Ko-Ting Lu; Xuebo Liu; Jing Wu; Deborah R Davis; Stella-Rita C Ibeawuchi; Silke Vogel; Frederick W Quelle; Curt D Sigmund
Journal:  JCI Insight       Date:  2017-03-23

7.  Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation.

Authors:  Hideki Ota; Masato Furuhashi; Shutaro Ishimura; Masayuki Koyama; Yusuke Okazaki; Tomohiro Mita; Takahiro Fuseya; Tomohisa Yamashita; Marenao Tanaka; Hideaki Yoshida; Kazuaki Shimamoto; Tetsuji Miura
Journal:  Am J Hypertens       Date:  2012-06-21       Impact factor: 2.689

8.  Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells.

Authors:  Gemma Aragonès; Paula Saavedra; Mercedes Heras; Anna Cabré; Josefa Girona; Lluís Masana
Journal:  Cardiovasc Diabetol       Date:  2012-06-18       Impact factor: 9.951

9.  Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes.

Authors:  Hong Wang; Jie Cao; Jian-Bin Su; Xue-Qin Wang; Xing Wang; Dong-Mei Zhang; Xiao-Hua Wang
Journal:  Diabetol Metab Syndr       Date:  2021-06-26       Impact factor: 3.320

10.  Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients.

Authors:  Anna Cabré; Pilar Valdovinos; Iolanda Lázaro; Gil Bonet; Alfredo Bardají; Lluís Masana
Journal:  Cardiovasc Diabetol       Date:  2013-05-04       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.